[go: up one dir, main page]

CA2565230A1 - Utilisation d'oxyde nitrique gazeux inhale en tant qu'agent mucolytique ou expectorant - Google Patents

Utilisation d'oxyde nitrique gazeux inhale en tant qu'agent mucolytique ou expectorant Download PDF

Info

Publication number
CA2565230A1
CA2565230A1 CA002565230A CA2565230A CA2565230A1 CA 2565230 A1 CA2565230 A1 CA 2565230A1 CA 002565230 A CA002565230 A CA 002565230A CA 2565230 A CA2565230 A CA 2565230A CA 2565230 A1 CA2565230 A1 CA 2565230A1
Authority
CA
Canada
Prior art keywords
nitric oxide
mammal
containing gas
oxide containing
airway
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002565230A
Other languages
English (en)
Inventor
Bruce Murray
Bryan Perry
Christopher C. Miller
Doug Hole
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pulmonox Technologies Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2565230A1 publication Critical patent/CA2565230A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
    • A61M16/021—Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes operated by electrical means
    • A61M16/022—Control means therefor
    • A61M16/024—Control means therefor including calculation means, e.g. using a processor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/02—Gases
    • A61M2202/0266—Nitrogen (N)
    • A61M2202/0275—Nitric oxide [NO]

Landscapes

  • Health & Medical Sciences (AREA)
  • Emergency Medicine (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CA002565230A 2004-05-11 2005-05-11 Utilisation d'oxyde nitrique gazeux inhale en tant qu'agent mucolytique ou expectorant Abandoned CA2565230A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US56988804P 2004-05-11 2004-05-11
US60/569,888 2004-05-11
PCT/US2005/016428 WO2005110052A2 (fr) 2004-05-11 2005-05-11 Utilisation d'oxyde nitrique gazeux inhale en tant qu'agent mucolytique ou expectorant

Publications (1)

Publication Number Publication Date
CA2565230A1 true CA2565230A1 (fr) 2005-11-24

Family

ID=35394611

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002565230A Abandoned CA2565230A1 (fr) 2004-05-11 2005-05-11 Utilisation d'oxyde nitrique gazeux inhale en tant qu'agent mucolytique ou expectorant

Country Status (3)

Country Link
AU (1) AU2005244079A1 (fr)
CA (1) CA2565230A1 (fr)
WO (1) WO2005110052A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12478640B2 (en) 2012-03-07 2025-11-25 Beyond Air Ltd Inhalation of nitric oxide for treating respiratory diseases

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7516742B2 (en) 1999-11-24 2009-04-14 Cardinal Health 207, Inc. Method and apparatus for delivery of inhaled nitric oxide to spontaneous-breathing and mechanically-ventilated patients with intermittent dosing
US7122018B2 (en) 2000-12-26 2006-10-17 Sensormedics Corporation Device and method for treatment of wounds with nitric oxide
US6432077B1 (en) 2000-12-26 2002-08-13 Sensormedics Corporation Device and method for treatment of surface infections with nitric oxide
US7531133B2 (en) 2002-09-10 2009-05-12 Pulmonox Technologies Corporation Use of nitric oxide gas in an extracorporeal circuitry to treat blood plasma
CA2563493A1 (fr) 2004-05-11 2005-11-24 Sensormedics Corporation Dosage intermittent d'oxyde nitrique gazeux
US8518457B2 (en) 2004-05-11 2013-08-27 Pulmonox Technologies Corporation Use of inhaled gaseous nitric oxide as a mucolytic agent or expectorant
US8079998B2 (en) 2006-10-20 2011-12-20 Pulmonox Technologies Corporation Methods and devices for the delivery of therapeutic gases including nitric oxide
JP2020513041A (ja) * 2017-04-10 2020-04-30 ザ ユニバーシティ オブ ノース カロライナ アット チャペル ヒルＴｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｎｏｒｔｈ Ｃａｒｏｌｉｎａ Ａｔ Ｃｈａｐｅｌ Ｈｉｌｌ 病原体の阻害および／または粘液の改変のための化合物、組成物、および方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9320978D0 (en) * 1993-10-12 1993-12-01 Higenbottam Timohy W Nitric oxide treatment
US5615669A (en) * 1994-07-22 1997-04-01 Siemens Elema Ab Gas mixture and device for delivering the gas mixture to the lungs of a respiratory subject
US6571790B1 (en) * 1997-05-12 2003-06-03 Robert E. Weinstein Method and device for organizing and coordinating the combined use of liquid medications for continuous nebulization for the treatment of respiratory disorders

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12478640B2 (en) 2012-03-07 2025-11-25 Beyond Air Ltd Inhalation of nitric oxide for treating respiratory diseases

Also Published As

Publication number Publication date
AU2005244079A1 (en) 2005-11-24
WO2005110052A2 (fr) 2005-11-24
WO2005110052A3 (fr) 2006-03-02

Similar Documents

Publication Publication Date Title
US10987377B2 (en) Use of inhaled gaseous nitric oxide as a mucolytic agent or expectorant
JP2019089775A (ja) 高濃度の一酸化窒素の投与法
SE506208C2 (sv) Anordning för uppsamling av gas från de övre luftvägarna och leverans av denna gas till inandningsluften i en respirator
CA2464443A1 (fr) Procede et dispositif de diagnostic utilisant un ecoulement d'air oscillant
CN105722543B (zh) 通过雾化施用肺表面活性剂的改进的方法和系统
EP2937089A1 (fr) Dispositif pour le traitement de, le traitement de complications résultant de, et/ou la prévention de troubles respiratoires
CA2565230A1 (fr) Utilisation d'oxyde nitrique gazeux inhale en tant qu'agent mucolytique ou expectorant
Matsuda et al. High-flow nasal cannula may not reduce the re-intubation rate compared with a large-volume nebulization-based humidifier
US20240075238A1 (en) Ventilator breathing circuit with a nebulizer between the ventilator and humidifier
US11464929B2 (en) System and method for vibratory, high frequency ventilation of neonates and infants
Abdelrahim et al. Essentials of Aerosol Therapy in Critically Ill Patients
Dieperink et al. Boussignac continuous positive airway pressure for weaning with tracheostomy tubes
AU2024202230A1 (en) Inhaled no for treating an adult patient with severe ards
RU18917U1 (ru) Аппарат искусственной вентиляции легких
Rahman et al. Rare fatal complications of acute fatty liver of pregnancy
Ahlers et al. Changes in serum cytokine levels during induced whole body hyperthermia
Bercker et al. Effects of stress-dose hydrocortisone therapy in septic shock (part II): soluble E-selectin and interleukin-6. Preliminary results of a double blinded, randomized, placebo-controlled cross-over study
Cohen et al. The Paracetamol Absorption Test (PAT): an obligatory addition to the enteral nutrition algorithm?
Bollero et al. GH and cortisol secretion in patients with burn on day 7 after thermal injury
Baguneid et al. Dopexamine reduces the incidence of colonic ischaemia following aortic surgery: a randomized placebo controlled study
Gleiβ et al. Sudden cardiac failure following treatment of metabolic alkalosis with hydrochloric acid
Meehan Management of respiratory failure caused by exacerbations
Oi et al. Effect of hypertonic dextran on intestinal mucosal perfusion during porcine endotoxin shock
Heringlake et al. The influence of aldosterone and angiotensin II on the diuretic effects of atrial natriuretic peptide in the isolated perfused rat kidney
Wegermann et al. Effects of spinal sympathicolysis on gastrointestinal motility in critically ill patients

Legal Events

Date Code Title Description
FZDE Dead